Dennis Gilbert has become CSO and vice president for research of Applied Biosystems, as well as vice president of Applera, the company said in an SEC filing last week. He joined Applera in 1994 as a research scientist and was most recently ABI’s vice president for advanced research and technology.
Frank Douglas has been appointed to fill a vacancy on the board of directors of Gene Logic with a term ending at the next annual stockholders meeting, at that time, he will be considered for election for a full term. Douglas recently retired from Aventis, where he served as executive vice president of drug innovation and approval and CSO.
Quantum Dot said last week that Janet Lankard has been named vice president of sales, and will lead the sales team for Quantum Dot’s upcoming launch of the Mosaic gene expression assay system. Lankard formerly was a director of sales for Affymetrix, which she joined in 1998. She has also been an executive sales account manager with Applied Biosystems, and was responsible for the Joint Genome Institute during the Human Genome Sequencing project. She serves on the Industrial Advisory Board for California Polytechnic State University. Lankard holds a BA in biochemistry from Cal Poly San Luis Obispo.
Nicolas Roelofs has resigned his position as COO of Stratagene effective Dec. 31. The resignation was disclosed in an SEC filing last week. Stratagene said Roelofs was leaving the firm to spend more time with his family. The company said it would search for a replacement upon his departure, and in the meantime CEO Joseph Sorge would assume Roelofs’ responsibilities.